You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 105 No. 2, February 1987 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Clinical characteristics of choroidal neovascular membranes

N. M. Bressler, S. B. Bressler and E. S. Gragoudas

Eighty-three choroidal neovascular membranes (CNVMs) associated with pathologic entities other than age-related macular degeneration (study group) were compared with 64 CNVMs associated with macular degeneration (comparison group). Nine CNVMs (11%) in the study group, compared with 28 CNVMs (44%) in the comparison group, were occult membranes. Of the remaining well-defined CNVMs, 16 (22%) in the study group, compared with 21 (58%) in the comparison group, were subfoveal. Of the well-defined subfoveal membranes, four (25%) in the study group, compared with 17 (81%) in the control group, were large (greater than 1500 micron in size). All large subfoveal membranes occurred in patients over 55 years of age. Thus, in this study the majority of CNVMs associated with pathologic entities other than age-related macular degeneration were well defined and not subfoveal at initial presentation. The majority of CNVMs associated with macular degeneration were occult or subfoveal. Membranes in patients over 55 years of age, regardless of cause, were commonly found to be occult or subfoveal at presentation.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Three-Dimensional Angiography of Classic and Occult Lesion Types in Choroidal Neovascularization
Schmidt-Erfurth et al.
IOVS 2007;48:1751-1760.
ABSTRACT | FULL TEXT  

Evaluation of the New Photosensitizer Tookad (WST09) for Photodynamic Vessel Occlusion of the Choroidal Tissue in Rabbits
Framme et al.
IOVS 2006;47:5437-5446.
ABSTRACT | FULL TEXT  

Iris Pigment Epithelial Translocation in the Treatment of Exudative Macular Degeneration: A 3-Year Follow-up.
Aisenbrey et al.
Arch Ophthalmol 2006;124:183-188.
ABSTRACT | FULL TEXT  

Morphometric Analysis of Angiograms of Exudative Lesions in Age-Related Macular Degeneration
Ali et al.
Arch Ophthalmol 2004;122:710-715.
ABSTRACT | FULL TEXT  

The Complications of Age-Related Macular Degeneration Prevention Trial (CAPT): rationale, design and methodology
The Complications of Age-Related Macular Degenerat
Clin Trials 2004;1:91-107.
ABSTRACT  

The Role of Adult Bone Marrow-Derived Stem Cells in Choroidal Neovascularization
Sengupta et al.
IOVS 2003;44:4908-4913.
ABSTRACT | FULL TEXT  

Visual Outcomes Following Macular Translocation With 360{degrees} Peripheral Retinectomy
Lai et al.
Arch Ophthalmol 2002;120:1317-1324.
ABSTRACT | FULL TEXT  

Eligibility for treatment and angiographic features at the early stage of exudative age related macular degeneration
Haddad et al.
Br. J. Ophthalmol. 2002;86:663-669.
ABSTRACT | FULL TEXT  

Macular Translocation With 360{degrees} Retinotomy for Exudative Age-Related Macular Degeneration
Aisenbrey et al.
Arch Ophthalmol 2002;120:451-459.
ABSTRACT | FULL TEXT  

Limited macular translocation with scleral retraction suture
Sullivan et al.
Br. J. Ophthalmol. 2002;86:434-439.
ABSTRACT | FULL TEXT  

Three-Dimensional Topographic Angiography in Chorioretinal Vascular Disease
Schmidt-Erfurth et al.
IOVS 2001;42:2386-2394.
ABSTRACT | FULL TEXT  

Electrophysiological changes after 360{degrees} retinotomy and macular translocation for subfoveal choroidal neovascularisation in age related macular degeneration
Luke et al.
Br. J. Ophthalmol. 2001;85:928-932.
ABSTRACT | FULL TEXT  

Treatment of subfoveal choroidal neovascularisation in age related macular degeneration: focus on clinical application of verteporfin photodynamic therapy
SOUBRANE and BRESSLER
Br. J. Ophthalmol. 2001;85:483-495.
FULL TEXT  

Photodynamic Therapy with Verteporfin (Visudyne): Impact on Ophthalmology and Visual Sciences
Bressler and Bressler
IOVS 2000;41:624-628.
FULL TEXT  

Clinicopathological correlation in exudative age related macular degeneration: histological differentiation between classic and occult choroidal neovascularisation
Lafaut et al.
Br. J. Ophthalmol. 2000;84:239-243.
ABSTRACT | FULL TEXT  

A Model of the Incidence and Consequences of Choroidal Neovascularization Secondary to Age-related Macular Degeneration: Comparative Effects of Current Treatment and Potential Prophylaxis on Visual Outcomes in High-Risk Patients
Lanchoney et al.
Arch Ophthalmol 1998;116:1045-1052.
ABSTRACT | FULL TEXT  

Correlation between Octopus perimetry and fluorescein angiography after strontium-90 plaque brachytherapy for subfoveal exudative age related macular degeneration
Jaakkola et al.
Br. J. Ophthalmol. 1998;82:763-768.
ABSTRACT | FULL TEXT  

A Locus for Autosomal Recessive Pseudoxanthoma Elasticum, with Penetrance of Vascular Symptoms in Carriers, Maps to Chromosome 16p13.1
van Soest et al.
Genome Res 1997;7:830-834.
ABSTRACT | FULL TEXT  

Diseases of the Retina
D'Amico
NEJM 1994;331:95-106.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.